How to Read a Weight Loss Study Without Getting Misled

A practicing physician's plain-language guide to telling real evidence from a marketing claim dressed up as science.

To read a weight loss study well, start with the average result and remember it is a midpoint, not a promise. Then check the sample size, how long the trial ran, and how many people dropped out. Read the placebo and lifestyle arms to see what the drug added. Prefer absolute numbers over percentages, and trace every claim back to its primary source.

I get asked some version of this question almost every week. A patient brings up a headline, a friend's testimonial, or a chart they saw on their phone, and they want to know whether it is true. My honest answer is usually: it depends on what is underneath the number. The good news is that you do not need a statistics degree to ask the right questions. You need a short checklist and a healthy, friendly skepticism. Let me walk you through the same things I look at.

What does "average weight loss" actually mean for me?

When a study reports an average, it is describing a whole group, not you. In the STEP-1 trial, adults taking semaglutide lost on average about 14.9 percent of their body weight. In SURMOUNT-1, the average with tirzepatide was about 20.9 percent. Those are real, meaningful figures from large randomized trials. But an average hides a spread. Some people in those studies lost far more, and some lost much less.

Think of it like a class test score. If the class average is 80, that tells you nothing about whether you personally scored 95 or 65. Your biology, your starting weight, your other health conditions, how consistently you take the medication, and how you eat and move all shift where you land in that spread. So when you see an average, translate it in your head: this is roughly the center of a wide range of outcomes. It is a useful planning number, not a guarantee. Results vary by individual, and any clinician who tells you otherwise is overselling.

How do I tell a clinical trial from a marketing claim?

This is the distinction that protects you most. A clinical trial is a structured experiment: people are enrolled under defined rules, often randomly assigned to a treatment or a comparison group, followed for a set time, and the results are written up so others can check the work. A marketing claim borrows the language of science without the structure underneath it.

A few questions separate the two quickly:

• Who was studied, and how many? A real trial names its participants and counts them.
• Was there a comparison group? Without something to compare against, you cannot know what the treatment actually added.
• Can you find the published source? Genuine research lives somewhere you can read it, not only in an ad.
• Does the claim hedge at all? Real science almost always describes limits. Pure marketing rarely does.

If a claim is built entirely on before-and-after photos and quotes, it may still be sincere, but it is testimony, not evidence. One person's story cannot tell you how the typical person does.

Why do sample size, length, and dropout rates matter?

These three details quietly decide how much you can trust a result. A study of twelve people can produce an impressive-looking number by chance alone. A study of hundreds or thousands is much harder to fool. So glance at the headcount first.

Length matters because weight loss is not a sprint. A drug that produces a quick four-week drop tells you very little about where someone sits at six or twelve months, which is the timeframe that actually affects health. Short studies can be honest and still answer the wrong question.

Dropout is the one most people skip, and it is the one I read most carefully. If a study starts with 200 people and only 120 finish, you have to ask why 80 left. Did they stop because of side effects? Because it was not working? If the final number only counts the people who stuck it out, the result can look better than real life, because the people for whom it went poorly have quietly disappeared from the math. A trustworthy study tells you its dropout rate and explains how it handled the people who left.

What are the placebo and lifestyle arms telling me?

In a well-run trial, not everyone gets the active treatment. Some get a placebo, and almost everyone gets lifestyle guidance on eating and activity. These comparison arms are not filler. They are the whole point.

Here is why. People in the placebo group often lose some weight too, partly from the lifestyle support, partly from the attention and structure of being in a study. So the real question is never "how much did the treatment group lose?" It is "how much more did they lose than the placebo group?" That gap is the drug's actual contribution. When a study reports both arms clearly, you can see the honest difference. When a study only shows you the treatment number in isolation, it is hiding the most useful comparison you have.

What is the difference between absolute and relative change?

This is where good people get genuinely misled, so it is worth slowing down. Relative numbers sound dramatic. Absolute numbers tell you what actually happened to bodies.

Imagine a claim that a product "doubled" weight loss. If the comparison group lost 2 pounds and the treatment group lost 4, that is technically a 100 percent improvement, and it is also only 2 extra pounds. The relative figure is true and the impression it creates is misleading. The same trick shows up with risk. Saying something "cut your risk by 50 percent" feels enormous, but if the risk went from 2 in 100 down to 1 in 100, the absolute change is one person per hundred.

My rule: whenever you see a percentage of a percentage, or a word like "doubled," "tripled," or "halved," pause and look for the plain numbers. How many pounds? How many people out of how many? If those figures are not offered, that absence is itself a signal.

How can I tell when a study is really an advertisement?

Some material is dressed in the costume of research to sell something. You can usually spot it. Watch for a few patterns:

• The result is described as guaranteed or works "for everyone." Real biology does not behave that way.
• There is no comparison group, no sample size, and no place to read the full study.
• The only evidence is testimonials, photos, or a single striking case.
• Every number is relative and dramatic, and no absolute figures appear.
• The conclusion happens to require buying a specific product, and the people who ran it stand to profit from that result.

None of this means the product is worthless. It means the evidence offered is not strong enough to base a decision on, and you are owed better before you spend money or change your health plan.

Where do I find the primary sources?

You are allowed to read the actual research, and it is more accessible than most people expect. PubMed, run by the National Library of Medicine, lets you search published medical studies for free and read summaries of nearly all of them. ClinicalTrials.gov lists registered trials, including ones still in progress. Many journals now post full studies openly. The trial names I mentioned, STEP-1, SURMOUNT-1, and SELECT, can all be searched directly.

When you find a study, read the abstract's results and the section on limitations, which is where careful authors admit what their work cannot prove. If something you were told does not appear in the primary source, that is worth knowing before you act on it.

One practical note for the medications I prescribe most. The brand drugs people recognize, semaglutide marketed as Ozempic and Wegovy (Novo Nordisk) and tirzepatide marketed as Mounjaro and Zepbound (Eli Lilly), are not affiliated with our clinic. We work with compounded semaglutide and tirzepatide, which are not FDA-approved and are not identical to the brand versions. The large trials describe the brand molecules, so they are a reasonable guide to what these medications can do, but your result is your own, and results vary by individual. The SELECT trial is also worth knowing about: it showed a cardiovascular benefit from semaglutide in adults who already had cardiovascular disease along with overweight or obesity, which is a reminder that these drugs are studied for more than the number on a scale.

If you want a clinician to read the evidence alongside you and help you weigh it honestly, that is exactly what a first visit is for. A consult at New Hope Weight Loss and Wellness is $119, and you are welcome to bring the headline that made you curious. I would rather you ask hard questions than trust a claim that cannot survive them.

Frequently asked questions

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.